This video explores new developments in the treatment of type 1 diabetes. It focuses on the underlying causes of type 1 diabetes, as well as on the new treatment technique described in the document "diabetes immunomodulation therapy through the Oral administration of a surfactant lipopeptide in NOD mice. " This includes a brief summary of the pancreatic islets and why a patient may experience hypersensitivity, as well as an explanation of the new treatment. The treatment involves the oral administration of fungicide WH1, derived from Bacillus amyloliquefaciens, to NOD mice (non-obese diabetics) to inhibit the activation of CD4 + T cells, therefore, the immune response associated with the pancreatic islets is reduced. Examples of how biotechnology was used in this study are also included, including ELISA, flow cytometry and FACS.
Video credits to a k YouTube channel